Cancerwise

Cancer treatment is increasingly tailored to the unique genetic makeup of each patient’s tumor. At the 2026 American Society for Clinical Oncology (ASCO) Annual Meeting, UT MD Anderson clinicians and researchers are showcasing breakthrough therapies targeting specific mutations and/or rare subsets of cancer, offering new hope for patients with historically hard-to-treat cancers.

Sharing our researchers’ findings and ideas at conferences...

Surgical procedures are a common part of cancer diagnosis and treatment, from a biopsy to determine the stage and type of cancer to the removal of a cancerous tumor from the body. Surgery continues to evolve as new advances and even small improvements make procedures easier for both surgeons and patients.

Jeff Siewerdsen, Ph.D., and his team are using data science and virtual models, like digital twin technology, to create these...